McGill Alert / Alerte de McGill

Updated: Mon, 07/15/2024 - 16:07

Gradual reopening continues on downtown campus. See Campus Public Safety website for details.

La réouverture graduelle du campus du centre-ville se poursuit. Complément d'information : Direction de la protection et de la prévention.

Event

Double Negative Control Inference in Test-Negative Design Studies of Vaccine Effectiveness

Wednesday, February 14, 2024 15:30to16:30

Xu Shi, PhD

Assistant Professor, Department of Biostatistics
University of Michigan

WHEN: Wednesday, February 14, 2024, from 3:30 to 4:30 p.m.

WHERE: hybrid | 2001 McGill College Avenue, room 1140; Zoom

NOTE: Dr. Shi will be presenting from Michigan

Abstract

The test-negative design (TND) has become a standard approach to evaluate vaccine effectiveness. Despite TND's potential to reduce unobserved differences in healthcare-seeking behavior (HSB) between vaccinated and unvaccinated subjects, it remains subject to various potential biases. First, residual confounding bias may remain due to unobserved HSB, occupation as a healthcare worker, or previous infection history. Second, because selection into the TND sample is a common consequence of infection and HSB, collider stratification bias may exist when conditioning the analysis on testing, which further induces confounding by latent HSB. Third, generalizability of the results to the general population is not guaranteed. In this talk, we present a novel approach to identify and estimate vaccine effectiveness in the general population by carefully leveraging a pair of negative control exposure and outcome variables to account for potential hidden bias in TND studies. We illustrate our proposed method with extensive simulation and an application to COVID-19 vaccine effectiveness using data from the University of Michigan Health System.

Speaker bio

Xu Shi is an Assistant Professor in the Department of Biostatistics at the University of Michigan. She is interested in developing statistical methods for electronic health records and claims data, focusing on causal inference, data harmonization across healthcare systems and comparative effectiveness and safety research.

Back to top